MEDICAL CODING INSTITUTE IN CALICUT

 

E88.01
 (Alpha-1-Antitrypsin Defficiency)

                                    An Alpha-1 carrier is a person who has one normal alpha-1 gene (M) and one defective alpha-1 gene (usually Z or S). Being a carrier is very common. It is believed that over 19 million people in the United States are carriers. Most Alpha-1 carriers are MZ or MS. When someone with alpha 1 antitrypsin has a baby with someone who is not a carrier, any child they have will be a carrier, but will not be affected. If your partner is a carrier of α1AT deficiency your children will have a 50 per cent chance of being a carrier and a 50 per cent chance of having α1AT deficiency. Alpha-1 antitrypsin deficiency is a genetic condition, meaning it is transmitted through an abnormal gene from parent to child. This gene is an autosomal recessive gene, which means that if the mom and the dad both carry the gene, 1 out of 4 of their children will inherit alpha-1 antitrypsin deficiency.


Alpha-1 antitrypsin deficiency is an inherited disorder that may cause lung disease and liver disease. The signs and symptoms of the condition and the age at which they appear vary among individuals.

People with alpha-1 antitrypsin deficiency usually develop the first signs and symptoms of lung disease between ages 25 and 50. The earliest symptoms are shortness of breath following mild activity, reduced ability to exercise, and wheezing. Other signs and symptoms can include unintentional weight loss, recurring respiratory infections, and fatigue. Affected individuals often develop emphysema, which is a lung disease caused by damage to the small air sacs in the lungs (alveoli). Characteristic features of emphysema include difficulty breathing, a hacking cough, and a barrel-shaped chest. Smoking or exposure to tobacco smoke accelerates the appearance of emphysema symptoms and damage to the lungs.

Mutations (changes) in the gene that produces the AAT protein cause Alpha-1. In people with the most common abnormal type of Alpha-1 (called ZZ type), AAT proteins are misshapen. These proteins can’t pass from the liver into the bloodstream, so the number of AAT proteins in the blood is low and the amount of AAT in the liver cells is increased.

When people have low AAT levels in the bloodstream, there isn’t enough AAT protein to protect the lungs and other organs from the effects of infection or irritants. Low levels of AAT can cause conditions such as emphysema and bronchitis (inflammation of the linings of the lungs). Your risk of developing lung problems with Alpha-1 increases a lot if you smoke.

Additionally, when AAT is unable to move out of the liver, it can build up and cause damage and scarring to the liver cells. This damage can lead to disorders such as cirrhosis and liver cancer





TREATMENTS OF ALPHA-1-ANTITRYPSIN DEFFICIENCY

  • Augmentation therapy: Doctors increase your AAT levels with donated AAT. If you have emphysemadue to Alpha-1, augmentation therapy may be considered and you may be recommended to receive weekly or monthly infusions (injections into a vein). This treatment may continue for the rest of your life.
  • Lung transplant: A new, healthy lung from a lung transplant can relieve respiratory problems.
  • Medication: Steroids and other drugs called bronchodilators can help make it easier for you to breathe by opening airways in the lungs.
  • Oxygen therapy: Receiving extra oxygen through a mask or tube in the nostrils can help you breathe more comfortably.
  • Pulmonary rehabilitation: Exercises and behavioral changes can relieve breathing problems to improve your daily functioning. Such therapy allows you to do more with the lung function that you have.





Location: No:29/867, First Floor Vijaya Apartment, PARAYANCHERI, Mavoor Rd, Parayancheri, Puthiyara, Kozhikode, Kerala 673016, India

Comments

Post a Comment

Popular posts from this blog

MEDICAL CODING IN CALICUT

Image
  A74.89     (OTHER CHLAMYDIAL DISEASES)                                 A74. 89 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.  Chlamydia infection is a common sexually transmitted infection in humans caused by the bacterium  Chlamydia trachomatis . The term Chlamydia infection can also refer to infection caused by any species belonging to the bacterial family Chlamydiaceae. C. trachomatis is found only in humans. Chlamydia is a major infectious cause of human genital and eye disease. Chlamydia infection is one of the most common sexually transmitted infections worldwide; it is estimated that about 1 million individuals in the United States are infected with chlamydia The bacterium Chlamydia trachomatis causes chlamydia. It can also cause other disorders, including: Pelvic inflammatory deseases Pneumonia Cervical infla...
Read more

MEDICAL CODING TRAINING IN CALICUT

Image
   N42.31  (PROSTATIC INTRAEPITHELIAL NEOPLASIA)                        A premalignant change arising in the prostatic epithelium, regarded as the most important and most likely precursor of prostatic adenocarcinoma. The  neoplasia   takes the form of an intra-acinar or ductal proliferation of secretory cells with unequivocal nuclear anaplasia, which corresponds to nuclear grade 2 and 3 invasive prostate cancer.    N42.31   is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reim bursement purposes. The 2021 edition of ICD-10-CM  N42.31  became effective on October 1, 2020. This is the American ICD-10-CM version of  N42.31  - other international versions of ICD-10  N42.31  may differ. Introduction: High-grade prostatic intraepithelial neoplasia (HGPIN) is generally accepted to be a precursor lesion of prostate cancer. The likely...
Read more

MEDICAL CODING TRAINING CENTRE IN CALICUT

Image
 E75.22  (GAUCHER DISEASE) An autosomal recessive disorder caused by a deficiency of acid beta-glucosidase (glucosylceramidase) leading to intralysosomal accumulation of  glycosylceramide  mainly in cells of the mononuclear phagocyte system. The characteristic gaucher cells, glycosphingolipid-filled histiocytes, displace normal cells in bone marrow and visceral organs causing skeletal deterioration, hepatosplenomegaly, and organ dysfunction. There are several subtypes based on the presence and severity of neurological involvement. An inherited lysosomal storage disease caused by deficiency of the enzyme glucocerebrosidase. It results in the accumulation of a fatty substance called glucocerebroside in mononuclear cells in the bone marrow, liver, spleen, brain, and kidneys. Signs and symptoms include hepatomegaly, splenomegaly, neurologic disorders, lymphadenopathy, skeletal disorders, anemia and thrombocytopenia. Autosomal recessive disorder caused by deficiency of th...
Read more